ARCHIVED — Vol. 150, No. 36 — September 3, 2016

Warning This Web page has been archived on the Web.

Archived Content

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

GOVERNMENT NOTICES

DEPARTMENT OF THE ENVIRONMENT

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Notice with respect to environmental occurrences notification agreements

Whereas on April 2, 2016, the Minister of the Environment published in the Canada Gazette, Part I, pursuant to subsection 9(2) of the Canadian Environmental Protection Act, 1999, a notice with respect to the availability of the proposed Environmental Occurrences Notification Agreements between the Government of Canada and the Governments of Alberta, British Columbia, Manitoba, Ontario, Saskatchewan, Northwest Territories and Yukon on the CEPA Environmental Registry Web site at www.ec.gc.ca/lcpe-cepa/eng/participation/default.cfm.

Whereas no notices of objection were filed and no comments were received in respect thereof;

Now therefore notice is hereby given, pursuant to subsection 9(4) of the Canadian Environmental Protection Act, 1999, that no notices of objection were filed and no comments were received by the Minister of the Environment during the consultation period.

Gatineau, August 19, 2016

Catherine McKenna
Minister of the Environment

[36-1-o]

DEPARTMENT OF HEALTH

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Publication of results of investigations for three substances — Beryllium, CAS RN (see footnote 1) 7440-41-7, Vanadium, trichlorooxo-, CAS RN 7727-18-6 and Vanadium oxide, CAS RN 11099-11-9 — specified on the Domestic Substances List (paragraph 68(b) of the Canadian Environmental Protection Act, 1999)

Whereas beryllium, vanadium, trichlorooxo- and vanadium oxide are substances on the Domestic Substances List identified under subsection 73(1) of the Canadian Environmental Protection Act, 1999;

Whereas a science approach document was developed pursuant to paragraph 68(b) of the Act, describing a scientific approach that was applied to three substances, in order to assess substances of low concern for human health based on human biomonitoring data;

Whereas a summary of the Science Approach Document conducted on the substances pursuant to paragraph 68(b) of the Act is annexed hereto;

And whereas the publication of the results will assist the Government in addressing substances that may be of low human health concern in a more effective manner,

Notice is hereby given that the human health component of screening assessments of the three substances, which will be conducted under section 74 of the Act, will be published at a later date and may be based in whole or in part on the analysis presented in this Science Approach Document.

Public comment period

Any person may, within 60 days after publication of this notice, file with the Minister of the Environment written comments on the scientific considerations presented in the Science Approach Document. More information regarding the scientific considerations may be obtained from the Government of Canada’s Chemical Substances Web site (www.chemicalsubstances.gc.ca). All comments must cite the Canada Gazette, Part I, and the date of publication of this notice and be sent to the Executive Director, Program Development and Engagement Division, Environment Canada, Gatineau, Quebec K1A 0H3, 819-938-5212 (fax), eccc.substances.eccc@canada.ca (email).

In accordance with section 313 of the Canadian Environmental Protection Act, 1999, any person who provides information in response to this notice may submit with the information a request that it be treated as confidential.

David Morin
Director General
Safe Environments Directorate
On behalf of the Minister of Health

ANNEX

Summary of the Science Approach Document

This Science Approach Document (SciAD) presents a qualitative biomonitoring-based approach to identify substances of low concern for human health that were identified as priorities for assessment, as they met categorization criteria under subsection 73(1) of the Canadian Environmental Protection Act, 1999 (CEPA).

This biomonitoring-based approach considers available Canadian and U.S. biomonitoring data based on the analysis of the substance or moiety in whole blood, serum, and/or urine. When biomonitoring data indicate that general population exposure is limited or unlikely, substances or moieties are considered to be of low concern with respect to human health. To determine if exposure is limited or unlikely, a number of metrics are taken into consideration, including the prevalence of exposure across the population, the magnitude of the biomarker concentration (if detected at the upper tails of the exposure distribution), the toxicokinetic properties of the substance or moiety, and the use pattern of the substance.

The application of this biomonitoring-based approach indicates that beryllium (CAS RN 7440-41-7) and two vanadium-containing substances, vanadium, trichlorooxo- (hereinafter referred to as trichlorooxo vanadium) [CAS RN 7727-18-6] and vanadium oxide (CAS RN 11099-11-9), would be of low concern with respect to human health at current levels of exposure.

An assessment of these substances conducted under section 74 of CEPA will be published at a later date.

A consultation period on this SciAD is being provided to the public, who will have an opportunity to provide comments and additional information in advance of this approach being applied in screening assessment reports. The publication of this scientific approach will assist the Government in addressing substances that are likely of low concern in an efficient and effective manner.

The Science Approach Document is available on the Government of Canada’s Chemical Substances Web site (www.chemicalsubstances.gc.ca).

[36-1-o]

DEPARTMENT OF HEALTH

CONTROLLED DRUGS AND SUBSTANCES ACT

Notice to interested parties — Proposed order amending Schedule VI to the Controlled Drugs and Substances Act and regulations amending the schedule to the Precursor Control Regulations to add chemicals used in the production of fentanyl

This notice provides interested stakeholders with the opportunity to provide comments on Health Canada’s intent to propose amendments to Schedule VI to the Controlled Drugs and Substances Act (CDSA) to add six chemicals that can be used in the production of fentanyl as Class A precursors. Amendments will also be proposed to add these chemicals to the schedule to the Precursor Control Regulations (PCR).

Schedule VI to the CDSA includes both Class A and Class B precursor chemicals. Class A precursors are essential chemical compounds (e.g. 1-Phenyl-2-propanone and Pseudoephedrine), while Class B precursors are common essential reagents, such as solvents, acids and bases. Both Class A and Class B precursors are commonly used in clandestine manufacturing processes.

Fentanyl is a potent synthetic opioid analgesic. According to the Canadian Community Epidemiology Network on Drug Use, between 2009 and 2014, there were at least 655 deaths in Canada where fentanyl was determined to be a contributing cause. Deaths involving fentanyl in a number of provinces have also increased markedly. Furthermore, increasing numbers of law enforcement drug seizures have been shown to contain fentanyl.

A Senate public bill proposing to address the growing fentanyl crisis by adding precursor chemicals used to produce fentanyl to Schedule VI to the CDSA was passed by the Senate in June 2016. While the Government of Canada supports this bill, in order to ensure that fentanyl precursors are controlled as soon as possible, it is proposed that the following six chemicals identified in Bill S-225 be added to Part 1 of Schedule VI to the CDSA and to the schedule to the PCR as Class A precursors:

  1. Propionyl chloride;
  2. 1-Phenethyl-4-piperidone and its salts;
  3. 4-Piperidone and its salts;
  4. Norfentanyl (N-phenyl-N-piperidin-4-ylpropanamide) and its salts;
  5. 1-Phenethylpiperidin-4-ylidenephenylamine and its salts; and
  6. N-Phenyl-4-piperidinamine and its salts.

The CDSA and its regulations provide a legislative framework for the control of substances that can alter mental processes and that may produce harm to individuals or to society when diverted to an illicit market or use. The Act and its regulations have the dual purpose of protecting public health and maintaining public safety by permitting access to these substances for legitimate industrial, medical or scientific purposes, while also mitigating the risks of trafficking and diversion to illicit markets and uses.

The PCR set out a licensing and permitting framework authorizing regulated parties to conduct activities with Class A or Class B precursors under certain circumstances. For example, only licensed dealers can import, export and produce Class A precursors, and a permit is required for individual imports and exports of Class A precursors. Licensed dealers must comply with requirements for record keeping, reporting and security specified in the Regulations.

Scheduling under the CDSA will provide law enforcement agencies with the authority to take action against activities that are not in accordance with the Act. The maximum penalty for indictable offences with respect to substances in Schedule VI is imprisonment for a term not exceeding 10 years. It is proposed that the six above-mentioned chemicals be listed on the schedule to the PCR so that they can be controlled like other Class A precursors.

Further to Health Canada’s five-point action plan to address the opioid crisis, this proposal would lead to further regulatory controls to support law enforcement in combatting illicit fentanyl production in Canada (http://healthycanadians.gc.ca/healthy-living-vie-saine/substance-abuse-toxicomanie/misuse-plan-abus-index-eng.php).

The publication of this notice in the Canada Gazette, Part I, initiates a 30-day comment period. Anyone interested in this process or anyone who has comments on this notice should contact Legislative and Regulatory Affairs, Controlled Substances Directorate, Healthy Environments and Consumer Safety Branch, Health Canada, by mail at Address Locator: 0302A, 150 Tunney’s Pasture Driveway, Ottawa, Ontario K1A 0K9, or by email at ocs_regulatorypolicy-bsc_politiquereglementaire@hc-sc.gc.ca.

September 3, 2016

Ana G. Renart
Director General
Controlled Substances Directorate

[36-1-o]

DEPARTMENT OF INDUSTRY

RADIOCOMMUNICATION ACT

Notice No. SMSE-016-16 — Release of RSS-210, Issue 9, and SP 462/467 MHz, Issue 2

Notice is hereby given that Innovation, Science and Economic Development Canada (ISED) has released an update to the following documents:

  • Radio Standards Specifications RSS-210, Issue 9, Licence-Exempt Radio Apparatus: Category I Equipment
  • Spectrum Utilization Policy, SP 462/467 MHz, Issue 2, Spectrum Utilization Policy to Permit Licence-Exempt Devices in the Land Mobile Frequency Sub-bands 462/467 MHz

Spectrum policy Radio Standards Specifications RSS-210 sets out the requirements for equipment certification of licence-exempt low-power radio apparatus for different services.

SP 462/467 MHz, Issue 2, is updated to allow the operation of General Mobile Radio Service-M (GMRS-M) in the 462 MHz frequency band and incorporates information from SP 462/467 MHz, Issue 1, and SP 462 MHz into a single policy document. Consequently, SP 462 MHz is now rescinded.

These documents will come into force upon their publication on ISED’s Spectrum Management and Telecommunications Official Publications page (http://www.ic.gc.ca/eic/site/smt-gst.nsf/eng/h_sf01841.html).

General information

The Radio Equipment Standards List will be amended accordingly.

Submitting comments

Interested parties are requested to provide their comments on RSS-210 within 90 days of the date of publication of this notice using the online General Inquiry form, at www.ic.gc.ca/res_general. Comments and suggestions for improving these standards may be submitted online, using the Standard Change Request form, at www.ic.gc.ca/res_change.

Obtaining copies

Copies of this notice and of documents referred to herein are available electronically on ISED’s Spectrum Management and Telecommunications Web site at www.ic.gc.ca/spectrum.

Official versions of Canada Gazette notices can be viewed at www.gazette.gc.ca/rp-pr/p1/index-eng.html.

August 2016

Martin Proulx
Acting Director General
Engineering, Planning and Standards Branch

[36-1-o]

OFFICE OF THE SUPERINTENDENT OF FINANCIAL INSTITUTIONS

BANK ACT

MB Financial Bank, National Association — Approval to have a financial establishment in Canada

Notice is hereby given, pursuant to subsection 522.21(1) of the Bank Act, that the Minister of Finance approved, on August 12, 2016, MB Financial Bank, National Association to have a financial establishment in Canada.

August 22, 2016

Jeremy Rudin
Superintendent of Financial Institutions

[36-1-o]

PRIVY COUNCIL OFFICE

Appointment opportunities

We know that our country is stronger — and our government more effective — when decision-makers reflect Canada’s diversity. Moving forward, the Government of Canada will use an appointment process that is transparent and merit-based, strives for gender parity, and ensures that Indigenous Canadians and minority groups are properly represented in positions of leadership. We will continue to search for Canadians who reflect the values that we all embrace: inclusion, honesty, fiscal prudence, and generosity of spirit. Together, we will build a government as diverse as Canada.

The Government of Canada is currently seeking applications from diverse and talented Canadians from across the country who are interested in the following positions.

Current opportunities

The following opportunities for appointments to Governor in Council positions are currently open for applications. Every opportunity is open for a minimum of two weeks from the date of posting on the Governor in Council Appointments Web site (http://www.appointments-nominations.gc.ca/slctnPrcs.asp?menu=1&lang=eng).

Position

Organization

Closing date

Chief Commissioner

Canadian Grain Commission

 

Assistant Chief Commissioner

Canadian Grain Commission

 

Commissioner

Canadian Grain Commission

 

Members

Historic Sites and Monuments Board of Canada

September 19, 2016

Upcoming opportunities

New opportunities that will be posted in the coming weeks.

Position

Organization

Full-time Member

National Energy Board

Chairperson

Patented Medicine Prices Review Board

Member

Patented Medicine Prices Review Board

Citizenship Judges

Citizenship Commission

Assistant Privacy Commissioner

Office of the Privacy Commissioner

Member

Military Judges Compensation Committee

Vice-Chairpersons (full-time and part-time positions)

Military Grievances External Review Committee

Members (full-time and part-time positions)

Military Grievances External Review Committee

Chairperson

Canadian Museum for Human Rights

Members

National Film Board

Members

National Capital Commission

Chairperson

National Gallery of Canada

Vice-Chairperson

National Gallery of Canada

Member

Telefilm Canada

President (Chief Executive Officer)

Atomic Energy of Canada Ltd

Chairperson

Atomic Energy of Canada Ltd

Directors

Atomic Energy of Canada Ltd

Member

Canada–Newfoundland and Labrador Offshore Petroleum Board

Member

Canada-Nova Scotia Offshore Petroleum Board

Chairperson

Marine Atlantic Inc.

Chairperson

Canadian Air Transport Security Authority Chairperson

Chairperson

VIA Rail Canada Inc.

Members

Canada Council for the Arts

Directors

Destination Canada (Canadian Tourism Commission)

Ongoing opportunities

Opportunities posted on an ongoing basis.

Position

Organization

Full-time and Part-time Members (Appeal Division)

Social Security Tribunal

Full-time and Part-time Members (General Division — Income Security Section)

Social Security Tribunal

Full-time and Part-time Members (General Division — Employment Insurance Section)

Social Security Tribunal

Full-time and Part-time Members

Immigration and Refugee Board

[36-1-o]

SUPREME COURT OF CANADA

SUPREME COURT ACT

Commencement of sessions

Pursuant to section 32 of the Supreme Court Act, notice is hereby given that the upcoming three sessions of the Supreme Court of Canada, for the purpose of hearing and determining appeals in 2016 and 2017, shall commence on the following days:

  • Fall Session 2016
    The Fall Session of the Supreme Court of Canada shall begin on Monday, October 3, 2016.
  • Winter Session 2017
    The Winter Session of the Supreme Court of Canada shall begin on Monday, January 9, 2017.
  • Spring Session 2017
    The Spring Session of the Supreme Court of Canada shall begin on Tuesday, April 18, 2017.

August 26, 2016

Roger Bilodeau, Q.C.
Registrar

[36-1-o]

  • Footnote 1
    The Chemical Abstracts Service Registry Number (CAS RN) is the property of the American Chemical Society, and any use or redistribution, except as required in supporting regulatory requirements and/or for reports to the Government of Canada when the information and the reports are required by law or administrative policy, is not permitted without the prior, written permission of the American Chemical Society.